Donor side effects experienced under minimal controlled ovarian stimulation (COS) with in vitro maturation (IVM) versus conventional COS for in vitro fertilization (IVF) treatment
Maria Marchante, Ferran Barrachina, Sabrina Piechota, Marta Fernandez-González, Alexa Giovannini, Trozalla Smith, Simone Kats, Bruna Paulsen, Eva González, Virginia Calvente, Ana Silvan, Baruch Abittan, Joshua Klein, Peter Klatsky, Daniel Ordonez, Christian C. Kramme
medRxiv 2024.03.28.24304995; doi: https://doi.org/10.1101/2024.03.28.24304995